Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap55.43M
Market cap55.43M
Price-Earnings ratio-1.01
Price-Earnings ratio-1.01
Dividend yield—
Dividend yield—
Average volume393.84K
Average volume393.84K
High today$0.39
High today$0.39
Low today$0.3702
Low today$0.3702
Open price$0.3702
Open price$0.3702
Volume236.44K
Volume236.44K
52 Week high$3.53
52 Week high$3.53
52 Week low$0.2928
52 Week low$0.2928
IMMP News
Simply Wall St 14h
Here's Why We're Watching Immutep's Cash Burn Situation - simplywall.st...
TipRanks 3d
Immutep upgraded to Buy from Hold at MaximMaxim analyst Jason McCarthy upgraded Immutep (IMMP) to Buy from Hold with a $1.50 price target Published first on TheFly – the ultimate source for real-time,...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.